BOULDER, Colo., Jan. 26, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the second quarter of fiscal 2016 and hold a conference call to discuss those results on Tuesday, February 2, 2016. Ron Squarer, Chief Executive Officer, will lead the call.
Date: Tuesday, February 2, 2016
Time: 9:00 a.m. Eastern Time
Toll-Free: (844) 464-3927
Toll: (765) 507-2598
Pass Code: 30840239
Webcast, including Replay and Conference Call Slides:
http://edge.media-server.com/m/p/bedxufnc
http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Tricia Haugeto Array BioPharma Inc. (303) 386-1193 thaugeto@arraybiopharma.com
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-report-financial-results-for-the-second-quarter-of-fiscal-2016-on-february-2-2016-300209980.html
SOURCE Array BioPharma Inc.